Intel Corp. is set to revamp its contract chip manufacturing business by pivoting away from its highly publicized 18A process and switching its attention to its next-generation 14A node in an ...

Dozens of companies have pledged to build more manufacturing in the U.S. since President Trump took office. Generic drugmakers aren’t among them. And they have no plans to change that anytime soon.

Globe Motors, a Dothan, Alabama manufacturing plant owned by Allied Motion, will lay off 73 employees. The layoffs represent a significant portion of the plant's approximately 200 employees.

American companies have for decades turned a blind eye to China’s authoritarianism, lured by cheaper goods while ignoring the nation’s hegemonic aims of a different world order.

The future biologics manufacturing site will serve several of UCB's goals. For one, the site "brings us closer to one of our fastest-growing markets," the company noted in its release.

Chipmaker Micron Technology Inc. said it will spend about $200 billion on US manufacturing, research and development, the latest company to pledge large-scale investments in the country since ...

More than 160 jobs will be eliminated next month with the closing of a St. Charles manufacturing plant. According to the Illinois Worker Adjustment and Retraining Notification report from the ...

The Commercial Reserve Manufacturing Network would include dual-use manufacturing firms qualified to produce military systems when called upon.

The final part of the manufacturing delusion is the idea that China’s industrial might is a product of its state-led economy—and so must be countered with a similarly extensive industrial ...

PepsiCo Foods U.S. confirmed that it a Frito-Lay plant in Rancho Cucamonga will be shutting down manufacturing operations.

A Frito-Lay manufacturing plant in Rancho Cucamonga has stopped production after more than 50 years in operation, and potentially hundreds of workers are now looking for new jobs. On Monday, a spok… ...

National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said it would “wind down” many of its facilities.